Showing results (81-90 of 97) with videos related to
Sort By:
Pageof 10
Circulation. Cardiovascular Interventions|February 2, 2010
Clinical feasibility of a fully automated 3D reconstruction of rotational coronary X-ray angiogramsAnne M Neubauer, Joel A Garcia, John C Messenger, et al.Diabetes, Obesity & Metabolism|August 6, 2013
Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patientsJ K Mader, K M Neubauer, L Schaupp, et al.Magnetic Resonance in Medicine|October 29, 2008
Gadolinium-modulated 19F signals from perfluorocarbon nanoparticles as a new strategy for molecular imagingAnne M Neubauer, Jacob Myerson, Shelton D Caruthers, et al.Science (New York, N.Y.)|May 14, 2005
Titan's magnetic field signature during the first Cassini encounterHeiko Backes, Fritz M Neubauer, Michele K Dougherty, et al.Journal of Cardiovascular Magnetic Resonance : Official Journal of the Society for Cardiovascular Magnetic Resonance|March 17, 2007
Fluorine cardiovascular magnetic resonance angiography in vivo at 1.5 T with perfluorocarbon nanoparticle contrast agentsAnne M Neubauer, Shelton D Caruthers, Franklin D Hockett, et al.Annals of Hematology|December 24, 1997
Randomized open label phase III trial of CEOP/IMVP-Dexa alternating chemotherapy and filgrastim versus CEOP/IMVP-Dexa alternating chemotherapy for aggressive non-Hodgkin's lymphoma (NHL). A multicenter trial by the Austrian Working Group for Medical Tumor TherapyM A Fridrik, R Greil, H Hausmaninger, et al.Science (New York, N.Y.)|September 13, 2008
The magnetic memory of Titan's ionized atmosphereC Bertucci, N Achilleos, M K Dougherty, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 8, 2007
19F magnetic resonance imaging for stem/progenitor cell tracking with multiple unique perfluorocarbon nanobeaconsKathryn C Partlow, Junjie Chen, Jason A Brant, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 1, 1996
CEOP-IMVP-Dexa in the treatment of aggressive lymphomas: an Austrian multicenter trialM A Fridrik, H Hausmaninger, W Linkesch, et al.European Journal of Cancer (Oxford, England : 1990)|January 20, 1999
Efficacy and toxicity of 2-Chlorodeoxyadenosine (Cladribine)--2 h infusion for 5 days--as first-line treatment for advanced low grade non-Hodgkin's lymphomaM A Fridrik, G Jäger, H R Kienzer, et al.Pageof 10